Major bleeding caused by warfarin in a genetically susceptible patient

Biochemistry, Genetics and Molecular Biology

• CYP2C9 100%
• Allele 50%
• Genetics 50%
• Anticoagulation 50%
• Isoenzyme 50%
• Cytochrome P450 50%
• Genetic Carrier 50%
• Heterozygote 50%
• Fresh Frozen Plasma 50%
• CYP2C9*3 50%
• Gene Mutation 50%

Keyphrases

• Warfarin 100%
• Major Bleeding 100%
• CYP2C9 37%
• International Normalized Ratio 25%
• Genetic Modification 12%
• Genetic Analysis 12%
• Compound Heterozygous mutation 12%
• Cytochrome P450 Enzymes 12%
• Enhanced Sensitivity 12%
• Life-threatening Complications 12%
• Older Women 12%
• Fresh Frozen Plasma 12%
• Patient Plasma 12%
• Variant Allele 12%
• Transfusion 12%
• 90 Years Old 12%
• Gastrointestinal Bleeding 12%
• Anticoagulation Effect 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Warfarin 100%
• Bleeding 100%
• CYP2C9 25%
• Cytochrome P450 Isoenzyme 12%
• CYP2C9*3 12%
• Gastrointestinal Hemorrhage 12%
• Fresh Frozen Plasma 12%